Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06271291
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.
Key Dates
- Start date
- Dec 12, 2024
- Status verified
- May 2026
- Primary completion
- Nov 1, 2029
- Completion
- Nov 1, 2029
Study Design
- Enrollment
- 30,000 participants (estimated)
Arms
- Arm: ObservationalParticipants undergo blood sample collection, complete questionnaires, have their medical records reviewed and undergo pancreatic cyst fluid collection during standard of care endoscopic ultrasounds fine needle aspiration.
Primary Outcome Measure
Develop a biobank of biospecimens and data of subjects without pancreatic cancer who are at high risk for pancreatic cancer [ Time Frame: Baseline (at enrollment) ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| HonorHealth Research Institute | Scottsdale | Arizona | 85258 | - |
| Piedmont Healthcare | Atlanta | Georgia | 30309 | Meiri Eyal, MD (PRINCIPAL_INVESTIGATOR) |
| OSF Saint Francis Medical Center | Peoria | Illinois | 61615 | Chandler Wilfong, MD (PRINCIPAL_INVESTIGATOR) |
| The Johns Hopkins University School of Medicine | Baltimore | Maryland | 21231 | Michael Goggins, MD (PRINCIPAL_INVESTIGATOR) |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Brian Wolpin, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Shounak Majumder, MD (PRINCIPAL_INVESTIGATOR) |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-6805 | Kelsey Klute, MD (PRINCIPAL_INVESTIGATOR) |
| Oregon Health & Science University | Portland | Oregon | 97201 | Rosalie Sears, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15232 | Randall Brand, MD 412-864-7516 Randall Brand, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
By condition
By specialty
Related Studies
- Use Of Indocyanine Green In Pancreas SurgeryRecruiting · OHSU Knight Cancer Institute · Portland, Oregon
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsPHASE2 · Recruiting · Daiichi Sankyo · Duarte, California
- Pancreatic Cancer Detection ConsortiumRecruiting · City of Hope Medical Center · Phoenix, Arizona
- A Study of MGC028 in Participants With Advanced Solid TumorsPHASE1 · Recruiting · MacroGenics · San Francisco, California